Beneficial effects of cysteamine in Thy1-α-Syn mice and induced pluripotent stem cells with a SNCA gene triplication
A number of publications have reported that cysteamine has significant therapeutic effects on several aspects of Parkinson's disease (PD)-related pathology but none of these studies have evaluated its impact on pathological forms of α-Synuclein (α-Syn), one of the main hallmarks of PD. We there...
Main Authors: | Alberto Siddu, Linda Suzanne David, Nadine Lauinger, Xiuqing Chen, Martine Saint-Pierre, Melanie Alpaugh, Thomas Durcan, Francesca Cicchetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096999612030317X |
Similar Items
-
Injection of α-syn-98 Aggregates Into the Brain Triggers α-Synuclein Pathology and an Inflammatory Response
by: Tingfu Du, et al.
Published: (2019-08-01) -
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
by: Mónica Gómez-Benito, et al.
Published: (2020-04-01) -
Effect of Parkin on methamphetamine‐induced α‐synuclein degradation dysfunction in vitro and in vivo
by: Yunle Meng, et al.
Published: (2020-04-01) -
Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
by: Anastazja M. Gorecki, et al.
Published: (2019-08-01) -
Alpha-synuclein and transgenic mouse models
by: Pierre-Olivier Fernagut, et al.
Published: (2004-11-01)